# Interpretation of Results IN PROGRESS

## Overview
This section explains how to interpret the outputs generated from the variant calling and annotation pipeline in the context of pharmacogenomics.

---

## 1. Variant Types

### SNPs (Single Nucleotide Polymorphisms)
- Single base changes in DNA
- Most common type of genetic variation

### Indels
- Insertions or deletions of bases
- Can cause frameshift mutations

---

## 2. Functional Consequences

Annotated variants are categorized based on their biological impact:

- **Synonymous variants**:
  No change in amino acid sequence

- **Missense variants**:
  Amino acid substitution; may affect protein function

- **Nonsense variants**:
  Premature stop codon; often results in truncated proteins

- **Frameshift variants**:
  Disrupt reading frame; typically high impact

---

## 3. Pharmacogenomic Relevance

Variants are evaluated for potential roles in:

- Drug metabolism (e.g., CYP enzymes)
- Drug targets
- Transport proteins

Particular attention is given to variants in genes previously associated with drug response.

---

## 4. Filtering Strategy Interpretation

Filtering removes low-confidence variants:

- Low QD → unreliable variant quality
- High FS → strand bias
- Low MQ → poor alignment confidence

Only high-confidence variants are used for downstream biological interpretation.

---

## 5. Annotation Outputs

Key columns from VEP:

- **Gene** → affected gene
- **Consequence** → predicted effect
- **IMPACT** → severity (HIGH, MODERATE, LOW)
- **Protein_position** → location in protein
- **Amino_acids** → reference vs variant amino acid

---

## 6. Downstream Analysis Potential

The annotated dataset can be used for:

- Identifying candidate pharmacogenes
- Pathway enrichment analysis
- Drug-gene interaction studies
- Precision medicine hypothesis generation

---

## Important Note
This project identifies *associations*, not causation. Functional validation is required to confirm biological effects.
